Central Trust CO Acadia Pharmaceuticals Inc Transaction History
Central Trust CO
- $3.97 Billion
- Q1 2025
A detailed history of Central Trust CO transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Central Trust CO holds 50 shares of ACAD stock, worth $736. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$736
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
328Shares Held
166MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$632 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$205 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$178 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$128 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$107 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.38B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...